Abstract
Burkholderia contaminans is a species of the Burkholderia cepacia complex, a group of bacteria that can grow in pharmaceutical products and are capable of infecting the immunocompromised and people with cystic fibrosis. Here, we report draft genome sequences for Burkholderia contaminans FFI-28, a strain isolated from a contaminated pharmaceutical solution.
GENOME ANNOUNCEMENT
Microbial contamination of pharmaceutical products and personal care products (PPCPs) pose a health threat for people with diseases that compromise their immune system, including cystic fibrosis (CF) patients (1, 2). In North America, the most common objectionable microorganism recovered during PPCP recalls are Burkholderia cepacia complex (BCC) bacteria (2, 3), which are resistant to most antibiotics and cause infections in CF patients (4, 5).
Burkholderia contaminans (6) is an emerging species of the BCC in CF infections. B. contaminans is prevalent in Argentina (7) and Portugal (8) and is being increasingly isolated in CF patients from Spain (9) and Ireland (10). B. contaminans has been linked to outbreaks due to contaminated pharmaceutical products (11, 12). Genome sequences of B. contaminans isolated from an Argentinian CF patient (13) and from soil (14) have been reported; however, there are no genomic data of isolates obtained from PPCPs. Thus, genome sequence analysis is expected to shed light on whether B. contaminans has an enhanced capacity to survive in harsh environments and harbors genetic elements coding for virulence factors. Here, we used Illumina sequencing to obtain a draft genome of B. contaminans FFI-28, a strain isolated in Argentina from a pharmaceutical solution.
Cultures were grown in LB, and genomic DNA was isolated using phenol-chloroform as per Sambrook et al. (15). The isolated genomic DNA was converted into a sequencing-ready library using the Nextera XT DNA sample preparation kit (Illumina). Illumina sequencing was performed in a MiSeq personal sequencing system at the Next Generation Sequencing Core Platform at the Manitoba Institute for Children’s Health.
The average genome coverage was 34×. Sequenced reads were merged using FLASH version 1.3.0 (16) and assembled de novo using the SPAdes assembler version 1.2 (17). The assembly of FFI-28 generated 239 contigs greater than 1,000 bp with a mean contig length of 35,018 bp and an N50 of 72,119 bp. The predicted genome size was 8.37 Mb with a GC content of 66.3. Species in the genus Burkholderia are known for having large multipart genomes, and the sizes of our assemblies fell within the range of 7.4 to 9.73 Mb seen in previously sequenced genomes (18). Annotation of the assemblies with RAST (19) identified 7,744 open reading frames, which fall within the range previously seen in BCC genomes.
To classify B. contaminans FFI-28 according to multilocus sequence typing (MLST) (20), we retrieved the sequences of recA, atpD, gltB, lepA, phaC, trpB, and gyrB alleles and compared them with those of the BCC MLST website (http://pubmlst.org/bcc). The analysis classified B. contaminans FFI-28 as belonging to the globally distributed sequence type 102 (21). This genomic resource provides a starting point for elucidating the role of contaminated PPCPs as a source of infection with an emerging BCC pathogen.
Accession number(s).
The B. contaminans FFI-28 draft genome has been deposited at DDBJ/ENA/GenBank under the accession number MDUI00000000. The version described in this paper is the first version, MDUI01000000.
ACKNOWLEDGMENTS
M.S.H. received travel funding from the Canadian Department of Foreign Affairs, Trade and Development (DFATD) through an Emerging Leaders in the Americas Program (ELAP) scholarship. This work was made possible by funding from the Canadian International Development Research Centre (IDRC), Canada-Latin America, and the Caribbean Research Exchange Grants Program (LACREG) (314933) and a University of Manitoba research grant (315366).
Footnotes
Citation Haim MS, Mollerach M, Van Domselaar G, Teves SA, Degrossi J, Cardona ST. 2016. Draft genome sequences of Burkholderia contaminans FFI-28, a strain isolated from a contaminated pharmaceutical solution. Genome Announc 4(5):e01177-16. doi:10.1128/genomeA.01177-16.
REFERENCES
- 1.Jimenez L. 2007. Microbial diversity in pharmaceutical product recalls and environments. PDA J Pharm Sci Technol 61:383–399. [PubMed] [Google Scholar]
- 2.Sutton S, Jimenez L. 2012. A review of reported recalls involving microbiological control 2004–2011 with emphasis on FDA considerations of “Objectionable organisms”. Rev Am Pharm Bus Tech 15:42. [Google Scholar]
- 3.Torbeck L, Raccasi D, Guilfoyle DE, Friedman RL, Hussong D. 2011. Burkholderia cepacia: this decision is overdue. PDA J Pharm Sci Technol 65:535–543. doi: 10.5731/pdajpst.2011.00793 [DOI] [PubMed] [Google Scholar]
- 4.Mahenthiralingam E, Urban TA, Goldberg JB. 2005. The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Microbiol 3:144–156. doi: 10.1038/nrmicro1085. [DOI] [PubMed] [Google Scholar]
- 5.Vandamme P, Dawyndt P. 2011. Classification and identification of the Burkholderia cepacia complex: past, present and future. Syst Appl Microbiol 34:87–95. doi: 10.1016/j.syapm.2010.10.002. [DOI] [PubMed] [Google Scholar]
- 6.Vanlaere E, Baldwin A, Gevers D, Henry D, De Brandt E, LiPuma JJ, Mahenthiralingam E, Speert DP, Dowson C, Vandamme P. 2009. Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. Int J Syst Evol Microbiol 59:102–111. doi: 10.1099/ijs.0.001123-0. [DOI] [PubMed] [Google Scholar]
- 7.Jorda-Vargas L, Castaneda NC, Centron D, Degrossi J, D’Aquino M, Valvano MA, Procopio A, Galanternik L. 2008. Prevalence of indeterminate genetic species of Burkholderia cepacia complex in a cystic fibrosis center in Argentina. J Clin Microbiol 46:1151–1152. doi: 10.1128/JCM.01595-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Coutinho CP, Barreto C, Pereira L, Lito L, Melo Cristino J, Sa-Correia I. 2015. Incidence of Burkholderia contaminans at a cystic fibrosis center with an unusually high representation of Burkholderia cepacia during 15 years of epidemiological surveillance. J Med Microbiol 64:927–935.doi: 10.1099/jmm.0.000094. [DOI] [PubMed] [Google Scholar]
- 9.Medina-Pascual MJ, Valdezate S, Carrasco G, Villalón P, Garrido N, Saéz-Nieto JA. 2015. Increase in isolation of Burkholderia contaminans from Spanish patients with cystic fibrosis. Clin Microbiol Infect 21:150–156. doi: 10.1016/j.cmi.2014.07.014. [DOI] [PubMed] [Google Scholar]
- 10.Power RF, Linnane B, Martin R, Power N, Harnett P, Casserly B, O’Connell NH, Dunne CP. 2016. The first reported case of Burkholderia contaminans in patients with cystic fibrosis in Ireland: from the Sargasso Sea to Irish children. BMC Pulm Med 16:57. doi: 10.1186/s12890-016-0219-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Martin M, Christiansen B, Caspari G, Hogardt M, von Thomsen AJ, Ott E, Mattner F. 2011. Hospital-wide outbreak of Burkholderia contaminans caused by prefabricated moist washcloths. J Hosp Infect 77:267–270. doi: 10.1016/j.jhin.2010.10.004. [DOI] [PubMed] [Google Scholar]
- 12.Moehring RW, Lewis SS, Isaacs PJ, Schell WA, Thomann WR, Althaus MM, Hazen KC, Dicks KV, Lipuma JJ, Chen LF, Sexton DJ. 2014. Outbreak of bacteremia due to Burkholderia contaminans linked to intravenous fentanyl from an institutional compounding pharmacy. JAMA Intern Med 174:606–612. doi: 10.1001/jamainternmed.2013.13768. [DOI] [PubMed] [Google Scholar]
- 13.Bloodworth RA, Selin C, López De Volder MA, Drevinek P, Galanternik L, Degrossi J, Cardona ST. 2015. Draft genome sequences of Burkholderia contaminans, a Burkholderia cepacia complex species that is increasingly recovered from cystic fibrosis patients. Genome Announc 3(4):e00766-15. doi: 10.1128/genomeA.00766-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Deng P, Wang X, Baird SM, Showmaker KC, Smith L, Peterson DG, Lu S. 2016. Comparative genome-wide analysis reveals that Burkholderia contaminans MS14 possesses multiple antimicrobial biosynthesis genes but not major genetic loci required for pathogenesis. MicrobiologyOpen 5:353–369. doi: 10.1002/mbo3.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Sambrook J, Russell DW. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. [Google Scholar]
- 16.Magoč T, Salzberg SL. 2011. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27:2957–2963. doi: 10.1093/bioinformatics/btr507. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, Lesin VM, Nikolenko SI, Pham S, Prjibelski AD, Pyshkin AV, Sirotkin AV, Vyahhi N, Tesler G, Alekseyev MA, Pevzner PA. 2012. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 19:455–477. doi: 10.1089/cmb.2012.0021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Ussery DW, Kiil K, Lagesen K, Sicheritz-Pontén T, Bohlin J, Wassenaar TM. 2009. The genus Burkholderia: analysis of 56 genomic sequences. Genome Dyn 6:140–157. doi: 10.1159/000235768. [DOI] [PubMed] [Google Scholar]
- 19.Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, Formsma K, Gerdes S, Glass EM, Kubal M, Meyer F, Olsen GJ, Olson R, Osterman AL, Overbeek RA, McNeil LK, Paarmann D, Paczian T, Parrello B, Pusch GD, Reich C, Stevens R, Vassieva O, Vonstein V, Wilke A, Zagnitko O. 2008. The RAST server: rapid annotations using subsystems technology. BMC Genomics 9:75. doi: 10.1186/1471-2164-9-75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Urwin R, Maiden MC. 2003. Multi-locus sequence typing: a tool for global epidemiology. Trends Microbiol 11:479–487. doi: 10.1016/j.tim.2003.08.006. [DOI] [PubMed] [Google Scholar]
- 21.Spilker T, Baldwin A, Bumford A, Dowson CG, Mahenthiralingam E, LiPuma JJ. 2009. Expanded multilocus sequence typing for Burkholderia species. J Clin Microbiol 47:2607–2610. doi: 10.1128/JCM.00770-09. [DOI] [PMC free article] [PubMed] [Google Scholar]